Intended for healthcare professionals

Papers And Originals

Combined Thyroxine and Triiodothyronine for Thyroid Replacement Therapy

Br Med J 1970; 2 doi: https://doi.org/10.1136/bmj.2.5704.270 (Published 02 May 1970) Cite this as: Br Med J 1970;2:270

This article has a correction. Please see:

  1. Selwyn Taylor,
  2. M. Kapur,
  3. Ross Adie

    Abstract

    Tablets containing 50μg. of thyroxine and 15μg. of triiodothyronine have been used to treat patients with hypothyroidism of varied aetiology. Following total thyroidectomy a daily dose of three tablets—that is, 150μg. of thyroxine and 45μg. of triiodothyronine—maintained patients in a euthyroid state and produced a protein-bound iodine level within the normal range. The preparation is preferable to dried thyroid because of uniformity of activity and speed of action, and when the patient is clinically euthyroid the P.B.I. falls within the normal range.

    Combined Thyroxine and Triiodothyronine for Thyroid Replacement Therapy Br Med J 1970; 2 :270 doi:10.1136/bmj.2.5704.270

    Help

    If you are unable to import citations, please contact technical support for your product directly (links go to external sites):

  • Forward this page

    Thank you for your interest in spreading the word about The BMJ.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    CAPTCHA

    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Topics

    This week's poll